CEFPODOXIME PROXETIL vs CEFTAZIDIME: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
CEFPODOXIME PROXETIL vs CEFTAZIDIME: Safety Overview
| Metric | CEFPODOXIME PROXETIL | CEFTAZIDIME |
|---|---|---|
| Total FAERS Reports | 323 | 3,158 |
| Deaths Reported | 5 | 696 |
| Death Rate | 1.5% | 22.0% |
| Hospitalizations | 160 | 1,503 |
| Average Patient Age | 52.9 yrs | 52.0 yrs |
| % Female Patients | 70.0% | 43.3% |
| FDA Approval Date | Aug 20, 2003 | Apr 28, 1989 |
| Manufacturer | Amici Pharmaceuticals, LLC. | Hospira, Inc. |
| Route | ORAL | INTRAVENOUS |
| Marketing Status | Discontinued | Discontinued |